| 摘要 |
The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed in response to peroxisome proliferator-activated receptor gamma (PPARgamma) agonist and which may be used entirely or in part to diagnose, to stage, to treat, or to monitor the progression or treatment of disorders such as diabetes mellitus, obesity, hypertension, atherosclerosis, polycystic ovarian syndrome, and cancers of the breast, prostate, or colon.
|
